These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11124594)

  • 21. A need for an individualized approach to end-stage renal disease patients.
    Hörl WH
    Nephrol Dial Transplant; 2002; 17 Suppl 6():17-21. PubMed ID: 12091597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of left ventricular hypertrophy after partial correction of anemia with erythropoietin in patients on hemodialysis: a prospective study.
    Pascual J; Teruel JL; Moya JL; Liaño F; Jiménez-Mena M; Ortuño J
    Clin Nephrol; 1991 Jun; 35(6):280-7. PubMed ID: 1831414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients.
    Xue JL; St Peter WL; Ebben JP; Everson SE; Collins AJ
    Am J Kidney Dis; 2002 Dec; 40(6):1153-61. PubMed ID: 12460033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuations in haemoglobin levels in haemodialysis, pre-dialysis and peritoneal dialysis patients receiving epoetin alpha or darbepoetin alpha.
    Walker R; Pussell BA;
    Nephrology (Carlton); 2009 Oct; 14(7):689-95. PubMed ID: 19796029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced responsiveness to epoetin at re-exposure after prolonged epoetin-free period in anemic hemodialysis patients with end-stage renal disease.
    Milutinović S; Trkulja V
    Croat Med J; 2006 Jun; 47(3):424-32. PubMed ID: 16758521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO).
    Jeren-Struji'c B; Raos V; Jeren T; Horvatin-Godler S
    Angiology; 2000 Feb; 51(2):131-9. PubMed ID: 10701721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis.
    Phrommintikul A; Haas SJ; Elsik M; Krum H
    Lancet; 2007 Feb; 369(9559):381-8. PubMed ID: 17276778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].
    Jungers PY; Nguyen-Khoa T; Joly D; Choukroun G; Massy ZA; Jungers P
    Presse Med; 2003 Feb; 32(5):212-6. PubMed ID: 12610461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular consequences of renal anaemia and erythropoietin therapy.
    Eckardt KU
    Nephrol Dial Transplant; 1999 May; 14(5):1317-23. PubMed ID: 10344393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
    Sikole A; Spasovski G; Zafirov D; Polenakovic M
    Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A; Salifu MO; Lunde NM; Bansal V; Fishbane S; Dougherty FC; Beyer U;
    Clin Ther; 2007 Apr; 29(4):626-39. PubMed ID: 17617286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of recombinant human erythropoietin, vitamin D3 and iron therapy on long-term survival of patients with end-stage renal disease receiving haemodialysis: analysis of 702 patients after 10-year follow-up.
    Chang HC; Chen CL; Chiu TL; Chen SI; Yen AM; Chen TH
    Public Health Nutr; 2009 Dec; 12(12):2410-5. PubMed ID: 19344540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morbidity and mortality reduction associated with the use of erythropoietin.
    Tsakiris D
    Nephron; 2000; 85 Suppl 1():2-8. PubMed ID: 10754421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD.
    Axelsson J; Qureshi AR; Heimbürger O; Lindholm B; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2005 Oct; 46(4):628-34. PubMed ID: 16183417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
    Hörl WH; Vanrenterghem Y; Canaud B; Mann J; Teatini U; Wanner C; Wikström B
    Nephrol Dial Transplant; 2005 May; 20 Suppl 3():iii25-32. PubMed ID: 15824127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probabilistic cost-minimisation analysis of darbepoetin alpha versus epoetin alpha in treating anaemia secondary to chronic renal failure. Assessment in Spanish clinical practice.
    Sanz-Granda A
    Farm Hosp; 2009; 33(4):208-16. PubMed ID: 19712609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity--the experience of the Lombardy Dialysis Registry.
    Locatelli F; Conte F; Marcelli D
    Nephrol Dial Transplant; 1998 Jul; 13(7):1642-4. PubMed ID: 9681705
    [No Abstract]   [Full Text] [Related]  

  • 38. What are the short-term and long-term consequences of anaemia in CRF patients?
    Mann JF
    Nephrol Dial Transplant; 1999; 14 Suppl 2():29-36. PubMed ID: 10334665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.
    Silberberg J; Racine N; Barre P; Sniderman AD
    Can J Cardiol; 1990; 6(1):1-4. PubMed ID: 2138048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure].
    Nikolaev AIu; Ermolenko VM; Milovanova LIu; Milovanov IuS
    Ter Arkh; 2004; 76(9):40-3. PubMed ID: 15532375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.